New stent graft aims to prevent deadly aneurysm rupture

NCT ID NCT04383145

Ongoing Disease control Sponsor: JOTEC GmbH Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a special stent graft system designed to treat thoracoabdominal aortic aneurysms, a life-threatening condition where the main artery bulges. The device is placed inside the artery to support the weakened wall and prevent rupture. Researchers are following 150 patients to see how well it works and how safe it is.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: E-nside TAAA multibranch stent graft system
What this could lead to: If successful, this device could offer a less invasive way to treat complex aortic aneurysms and reduce the risk of rupture and death.
What could go wrong: This is a post-market study, so the device is already approved. However, it is still being evaluated in a moderate-sized group, and risks like rupture or major adverse events remain possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for THORACOABDOMINAL AORTIC ANEURYSM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Aneurysm aortic aneurysm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

VASCULAR ANEURYSM

Contacts and locations

Locations

Universitätsklinikum Heidelberg

Heidelberg, 69120, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.